Karen Smith
Directeur/Membre du Conseil chez EMYRIA LIMITED
Fortune : 205 077 $ au 31/05/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Michael Martin | M | 52 | 31 ans | |
| Robert Foster | M | 65 | 31 ans | |
| Peter Greenleaf | M | 54 | 6 ans | |
| Michael Winlo | M | - | 5 ans | |
| Stephen Robertson | M | 42 | 10 ans | |
| Alexander Macrae | M | 61 | 8 ans | |
| Prathyusha Durabaibu | F | 45 | 5 ans | |
| Aaron Rosenberg | M | - | 3 ans | |
| Simon Read | M | - |
Mariana Oncology, Inc.
 Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | - |
| Daniel Billen | M | 70 | 5 ans | |
| Philip Low | M | 76 |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | 2 ans |
| Laura Shawver | M | 66 |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company based in San Diego, CA. Capstan Therapeutics aims to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. The company's platform technology, TLNPs, is designed to deliver payloads and gene editing tools to reprogram specific cell types in vivo. This technology has the potential to generate transformative therapies for various disease areas, including autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. Capstan Therapeutics, Inc. was founded in 2022 by Haig Aghajanian. Laura K. Shawver has been the CEO of the company since 2022. | 2 ans |
| H. Parker | F | 68 | 10 ans | |
| Louise Wilkie | F | - | 4 ans | |
| Kimberly McCutcheon Jablonski | F | - | 21 ans | |
| Haig Aghajanian | M | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company based in San Diego, CA. Capstan Therapeutics aims to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. The company's platform technology, TLNPs, is designed to deliver payloads and gene editing tools to reprogram specific cell types in vivo. This technology has the potential to generate transformative therapies for various disease areas, including autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. Capstan Therapeutics, Inc. was founded in 2022 by Haig Aghajanian. Laura K. Shawver has been the CEO of the company since 2022. | 2 ans |
| Lexi O’Halloran | F | - | - | |
| Scott Willoughby | M | - | - | |
| June Bray | F | 70 | 2 ans | |
| Karen Smith | F | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company based in San Diego, CA. Capstan Therapeutics aims to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. The company's platform technology, TLNPs, is designed to deliver payloads and gene editing tools to reprogram specific cell types in vivo. This technology has the potential to generate transformative therapies for various disease areas, including autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. Capstan Therapeutics, Inc. was founded in 2022 by Haig Aghajanian. Laura K. Shawver has been the CEO of the company since 2022. | - |
| John Markels | M | 58 | 4 ans | |
| Margaret Somerville | F | - | - | |
| Stewart A. Low | M | - |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | - |
| Phillip Ramsey | M | - | - | |
| Sandy Mong | M | - |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | - |
| James Meyers | M | 59 | 5 ans | |
| Brinda Balakrishnan | M | 44 | 3 ans | |
| Jeffrey Bailey | M | 62 | 1 ans | |
| Duncan Moore | M | 65 | 8 ans | |
| R. MacKay-Dunn | M | 73 | 5 ans | |
| Kenneth Hillan | M | 63 | 4 ans | |
| Robert Carey | M | 65 | 8 ans | |
| Jill Leversage | F | 67 | 5 ans | |
| Helen Torley | M | 61 | 8 ans | |
| Gregory Davis | M | - | 4 ans | |
| Jon Filderman | M | - | 3 ans | |
| Linda Bain | F | 53 |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | 1 ans |
| Daniel Hasler | M | 66 |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | - |
| Greg Hutchinson | M | - | 1 ans | |
| David Jaynee | M | 67 | 9 ans | |
| Simon Read | M | 53 |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | 3 ans |
| Scott Habig | M | 64 | 2 ans | |
| Tim Power | M | - | 18 ans | |
| Jamie Bernard | M | - | 4 ans | |
| Sue Evans | F | - | 10 ans | |
| Matthew Donley | M | 55 | 5 ans | |
| Tracie Ernenwein | F | - | - | |
| Amy Pooler | F | - | - | |
| Jerome Mychalowych | M | - | 3 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Robert F. Apple | M | 58 | 16 ans | |
| Christopher Lowe | M | 56 | 3 ans | |
| Jeffrey Edwards | M | 63 | 22 ans | |
| Peter J. Graham | M | 57 | 7 ans | |
| James Hindman | M | 63 | 31 ans | |
| James Cornelius | M | 81 | 10 ans | |
| Peter R. Dolan | M | 68 | 18 ans | |
| Steven R. Deitcher | M | 59 |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | - |
| Joseph Zakrzewski | M | 60 | 11 ans | |
| Leonard S. Jacob | M | 75 | 15 ans | |
| Caryn McDowell | F | 54 | 2 ans | |
| Ambrose Bailey | M | 60 | - | |
| Ted Monohon | M | 58 | 4 ans | |
| David Pyott | M | 70 | 17 ans | |
| Gary Loeb | M | 54 | 2 ans | |
| Jacques Gonella | M | 82 | 18 ans | |
| Habib Dable | M | 54 | 5 ans | |
| Vivid Sehgal | M | 56 | 8 ans | |
| Herb Boyer | M | 87 | 19 ans | |
| Kathy Yi | F | 52 | 2 ans | |
| Francois Nader | M | 67 | 7 ans | |
| John Quisel | M | 52 | 14 ans | |
| Thomas McCourt | M | 66 | 5 ans | |
| Heather Erickson | F | - | 8 ans | |
| Rita Karachun | F | 61 | - | |
| Michael Holmes | M | - | 17 ans | |
| Sona Saira Ramasastry | F | 48 | 10 ans | |
| R. Ramelmeier | M | 62 | 5 ans | |
| John Tsai | M | 57 | 11 ans | |
| Russell Cox | M | 60 | 6 ans | |
| Christopher Rovaldi | M | 50 | 11 ans | |
| Laura Hamill | F | 60 | 1 ans | |
| David J. Helfgott | M | - | - | |
| Edward Rebar | M | 56 | 22 ans | |
| Roger Jeffs | M | 62 | 2 ans | |
| Harrison Bains | M | 80 | 16 ans | |
| Louis J. Freeh | M | 74 | 8 ans | |
| Robert Williams | M | 75 | 7 ans | |
| Heather Turner | F | 51 | 1 ans | |
| Richard Pops | M | 62 | 15 ans | |
| Vicki Sato | M | 75 | 15 ans | |
| Jean George | F | 66 | 15 ans | |
| Douglas Manion | M | 64 | 11 ans | |
| Tram Bui | F | - | 2 ans | |
| Steven Mento | M | 72 | 14 ans | |
| Gerald Bruce | M | 68 | 8 ans | |
| Mark W. Durand | M | 64 | 17 ans | |
| Kemal Malik | M | 61 | - | |
| George Golumbeski | M | 67 | 7 ans | |
| Rahul Khara | M | - | 3 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 80 | 80,81% |
| Canada | 13 | 13,13% |
| Australie | 5 | 5,05% |
| Danemark | 1 | 1,01% |
| Irlande | 1 | 1,01% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Karen Smith
- Réseau Personnel
